Collectively, our results expose the complex interplay between Akt isoforms and a compensatory mechanism in Akt signaling in the RPE during the progression of DR and identify a pathway that could be manipulated to develop new therapies for the treatment of diabetic eye disease (Fig. 10). This evidence concerns the gene AKT1 and diabetic eye disease.